The present invention provides isolated peptides or immunogenic fragments derived from SEQ ID NO: 69 that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the afore-mentioned amino acid sequences with or without the substitution, deletion, or addition of one, two, or several amino acids sequences. The present invention also provides pharmaceutical compositions containing such peptides. The peptides of this invention find utility in the treatment of cancer.本發明提供來自序列辨識號：69之經分離的胜肽或免疫活性片段，其與一人類白血球組織抗原結合且誘發細胞毒殺性T淋巴球。此胜肽可具有或不具有一、二或數個胺基酸序列之取代、刪除或加入。本發明也提供包含此類胜肽之藥學組合物。本發明之胜肽於癌症之治療中提供效用。
